{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T04:03:22Z","timestamp":1779336202180,"version":"3.51.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,7,30]],"date-time":"2013-07-30T00:00:00Z","timestamp":1375142400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1742-2094-10-97","type":"journal-article","created":{"date-parts":[[2013,7,30]],"date-time":"2013-07-30T16:14:27Z","timestamp":1375200867000},"source":"Crossref","is-referenced-by-count":20,"title":["Chronic oral administration of minocycline to sheep with ovine CLN6 neuronal ceroid lipofuscinosis maintains pharmacological concentrations in the brain but does not suppress neuroinflammation or disease progression"],"prefix":"10.1186","volume":"10","author":[{"given":"Graham W","family":"Kay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David N","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,7,30]]},"reference":[{"key":"900_CR1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ajmg.1320310606","volume":"Suppl 5","author":"JA Rider","year":"1988","unstructured":"Rider JA, Rider DL: Batten disease: past, present, and future. Am J Med Genet 1988, Suppl 5:21\u201326.","journal-title":"Am J Med Genet"},{"key":"900_CR2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/humu.21624","volume":"33","author":"M Kousi","year":"2012","unstructured":"Kousi M, Lehesjoki AE, Mole SE: Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses. Hum Mutat 2012, 33:42\u201363.","journal-title":"Hum Mutat"},{"key":"900_CR3","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1093\/hmg\/dds089","volume":"21","author":"J Bras","year":"2012","unstructured":"Bras J, Verloes A, Schneider SA, Mole SE, Guerreiro RJ: Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis. Hum Mol Genet 2012, 21:2646\u20132650.","journal-title":"Hum Mol Genet"},{"key":"900_CR4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ajhg.2011.07.003","volume":"89","author":"L Noskov\u00e1","year":"2011","unstructured":"Noskov\u00e1 L, Str\u00e1neck\u00fd V, Hartmannov\u00e1 H, P\u0159istoupilov\u00e1 A, Bare\u0161ov\u00e1 V, Iv\u00e1nek R, H\u016flkov\u00e1 H, Jahnov\u00e1 H, van der Zee J, Staropoli JF, Sims KB, Tyynel\u00e4 J, Van Broeckhoven C, Nijssen PC, Mole SE, Elleder M, Kmoch S: Mutations in DNAJC5 , encoding cysteine-string protein alpha, cause autosomal-dominant adult-onset neuronal ceroid lipofuscinosis. Am J Hum Genet 2011, 89:241\u2013252.","journal-title":"Am J Hum Genet"},{"key":"900_CR5","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/hmg\/dds558","volume":"22","author":"KR Smith","year":"2013","unstructured":"Smith KR, Dah HHM, Canafoglia L, Andermann E, Damiano J, Morbin M, Bruni AC, Giaccone G, Cossette P, Saftig P, Gr\u00f6tzinger J, Schwake M, Andermann F, Staropoli JF, Sims KB, Mole SE, Franceschetti S, Alexander NA, Cooper JD, Chapman HA, Carpenter S, Berkovic SF, Bahlo M: Cathepsin F mutations cause Type B Kufs disease, an adult-onset neuronal ceroid lipofuscinosis. Hum Mol Genet 2013, 22:1417\u20131423.","journal-title":"Hum Mol Genet"},{"key":"900_CR6","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.bbadis.2006.09.004","volume":"1762","author":"I Tammen","year":"2006","unstructured":"Tammen I, Houweling PJ, Frugier T, Mitchell NL, Kay GW, Cavanagh JAL, Cook RW, Raadsma HW, Palmer DN: A missense mutation (c.184C > T) in ovine CLN6 causes neuronal ceroid lipofuscinosis in Merino sheep whereas affected South Hampshire sheep have reduced levels of CLN6 mRNA. Biochim Biophys Acta 2006, 1762:898\u2013905.","journal-title":"Biochim Biophys Acta"},{"key":"900_CR7","doi-asserted-by":"crossref","first-page":"5736","DOI":"10.1016\/S0021-9258(18)83610-9","volume":"264","author":"DN Palmer","year":"1989","unstructured":"Palmer DN, Martinus RD, Cooper SM, Midwinter GG, Reid JC, Jolly RD: Ovine ceroid-lipofuscinosis. The major lipopigment protein and the lipid-binding subunit of mitochondrial ATP synthase have the same NH 2 -terminal sequence. J Biol Chem 1989, 264:5736\u20135740.","journal-title":"J Biol Chem"},{"key":"900_CR8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/ajmg.1320420428","volume":"42","author":"DN Palmer","year":"1992","unstructured":"Palmer DN, Fearnley IM, Walker JE, Hall NA, Lake BD, Wolfe LS, Haltia M, Martinus RD, Jolly RD: Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease). Am J Med Genet 1992, 42:561\u2013567.","journal-title":"Am J Med Genet"},{"key":"900_CR9","doi-asserted-by":"crossref","first-page":"21883","DOI":"10.1074\/jbc.M402074200","volume":"279","author":"R Chen","year":"2004","unstructured":"Chen R, Fearnley IM, Palmer DN, Walker JE: Lysine 43 is trimethylated in subunit c from bovine mitochondrial ATP synthase and in storage bodies associated with Batten disease. J Biol Chem 2004, 279:21883\u201321887.","journal-title":"J Biol Chem"},{"key":"900_CR10","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/med\/9780199590018.003.0018","volume-title":"The neuronal ceroid lipofuscinoses (Batten disease)","author":"DN Palmer","year":"2011","unstructured":"Palmer DN, Tammen I, Dr\u00f6gem\u00fcller C, Johnson GS, Katz ML, Lingaas F: Large animal models. In The neuronal ceroid lipofuscinoses (Batten disease). 2nd edition. Edited by: Mole SE, Williams RE, Goebel HH. New York: Oxford University Press; 2011:284\u2013320.","edition":"2"},{"key":"900_CR11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.nbd.2008.06.004","volume":"32","author":"MJ Oswald","year":"2008","unstructured":"Oswald MJ, Palmer DN, Kay GW, Barwell KJ, Cooper JD: Location and connectivity determine GABAergic interneuron survival in the brains of South Hampshire sheep with CLN6 neuronal ceroid lipofuscinosis. Neurobiol Dis 2008, 32:50\u201365.","journal-title":"Neurobiol Dis"},{"key":"900_CR12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.nbd.2005.01.025","volume":"20","author":"MJ Oswald","year":"2005","unstructured":"Oswald MJ, Palmer DN, Kay GW, Shemilt SJA, Rezaie P, Cooper JD: Glial activation spreads from specific cerebral foci and precedes neurodegeneration in presymptomatic ovine neuronal ceroid lipofuscinosis (CLN6). Neurobiol Dis 2005, 20:49\u201363.","journal-title":"Neurobiol Dis"},{"key":"900_CR13","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1750-3639.2006.00002.x","volume":"16","author":"GW Kay","year":"2006","unstructured":"Kay GW, Palmer DN, Rezaie P, Cooper JD: Activation of non-neuronal cells within the prenatal developing brain of sheep with neuronal ceroid lipofuscinosis. Brain Pathol 2006, 16:110\u2013116.","journal-title":"Brain Pathol"},{"key":"900_CR14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0165-0173(99)00007-7","volume":"30","author":"G Raivich","year":"1999","unstructured":"Raivich G, Bohatschek M, Kloss CUA, Werner A, Jones LL, Kreutzberg GW: Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function. Brain Res Rev 1999, 30:77\u2013105.","journal-title":"Brain Res Rev"},{"key":"900_CR15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0301-0082(98)00083-5","volume":"58","author":"G Stoll","year":"1999","unstructured":"Stoll G, Jander S: The role of microglia and macrophages in the pathophysiology of the CNS. Prog Neurobiol 1999, 58:233\u2013247.","journal-title":"Prog Neurobiol"},{"key":"900_CR16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-1-14","volume":"1","author":"WJ Streit","year":"2004","unstructured":"Streit WJ, Mrak RE, Griffin WST: Microglia and neuroinflammation: a pathological perspective. J Neuroinflammation 2004, 1:14.","journal-title":"J Neuroinflammation"},{"key":"900_CR17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/glia.1108","volume":"36","author":"H Neumann","year":"2001","unstructured":"Neumann H: Control of glial immune function by neurons. Glia 2001, 36:191\u2013199.","journal-title":"Glia"},{"key":"900_CR18","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s00702-006-0575-6","volume":"113","author":"P Eikelenboom","year":"2006","unstructured":"Eikelenboom P, Veerhuis R, Scheper W, Rozemuller AJM, van Gool WA, Hoozemans JJM: The significance of neuroinflammation in understanding Alzheimer\u2019s disease. J Neural Transm 2006, 113:1685\u20131695.","journal-title":"J Neural Transm"},{"key":"900_CR19","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/emm.2006.40","volume":"38","author":"YS Kim","year":"2006","unstructured":"Kim YS, Joh TH: Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson\u2019s disease. Exp Mol Med 2006, 38:333\u2013347.","journal-title":"Exp Mol Med"},{"key":"900_CR20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.nbd.2004.07.012","volume":"17","author":"D Blum","year":"2004","unstructured":"Blum D, Chtarto A, Tenenbaum L, Brotchi J, Levivier M: Clinical potential of minocycline for neurodegenerative disorders. Neurobiol Dis 2004, 17:359\u2013366.","journal-title":"Neurobiol Dis"},{"key":"900_CR21","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bbr.2008.09.040","volume":"196","author":"HS Kim","year":"2009","unstructured":"Kim HS, Suh YH: Minocycline and neurodegenerative diseases. Behav Brain Res 2009, 196:168\u2013179.","journal-title":"Behav Brain Res"},{"key":"900_CR22","doi-asserted-by":"crossref","first-page":"15769","DOI":"10.1073\/pnas.95.26.15769","volume":"95","author":"J Yrj\u00e4nheikki","year":"1998","unstructured":"Yrj\u00e4nheikki J, Kein\u00e4nen R, Pellikka M, H\u00f6kfelt T, Koistinaho J: Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci (USA) 1998, 95:15769\u201315774.","journal-title":"Proc Natl Acad Sci (USA)"},{"key":"900_CR23","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1111\/j.1460-9568.2012.08276.x","volume":"36","author":"HE Reinebrant","year":"2012","unstructured":"Reinebrant HE, Wixey JA, Buller KM: Disruption of raph\u00e9 serotonergic neural projections to the cortex: a potential pathway contributing to remote loss of brainstem neurons following neonatal hypoxic-ischemic brain injury. Eur J Neurosci 2012, 36:3483\u20133491.","journal-title":"Eur J Neurosci"},{"key":"900_CR24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3389\/fneur.2012.00111","volume":"3","author":"E Kovesdi","year":"2012","unstructured":"Kovesdi E, Kamnaksh A, Wingo D, Ahmed F, Grunberg NE, Long JB, Kasper CE, Agoston DV: Acute minocycline treatment mitigates the symptoms of mild blast-induced traumatic brain injury. Front Neurol 2012, 3:111.","journal-title":"Front Neurol"},{"key":"900_CR25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1742-2094-9-62","volume":"9","author":"MT Ferretti","year":"2012","unstructured":"Ferretti MT, Allard S, Partridge V, Ducatenzeiler A, Cuello AC: Minocycline corrects early, pre-plaque neuroinflammation and inhibits BACE-1 in a transgenic model of Alzheimer\u2019s disease-like amyloid pathology. J Neuroinflammation 2012, 9:62.","journal-title":"J Neuroinflammation"},{"key":"900_CR26","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s12640-012-9315-x","volume":"22","author":"H Kalonia","year":"2012","unstructured":"Kalonia H, Mishra J, Kumar A: Targeting neuro-inflammatory cytokines and oxidative stress by minocycline attenuates quinolinic-acid-induced Huntington\u2019s disease-like symptoms in rats. Neurotox Res 2012, 22:310\u2013320.","journal-title":"Neurotox Res"},{"key":"900_CR27","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.2527\/1991.69114512x","volume":"69","author":"A Pijpers","year":"1991","unstructured":"Pijpers A, Schoevers EJ, Haagsma N, Verheijden JH: Plasma levels of oxytetracycline, doxycycline, and minocycline in pigs after oral administration in feed. J Anim Sci 1991, 69:4512\u20134522.","journal-title":"J Anim Sci"},{"key":"900_CR28","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.expneurol.2003.12.006","volume":"186","author":"SC Fagan","year":"2004","unstructured":"Fagan SC, Edwards DJ, Borlongan CV, Xu L, Arora A, Feuerstein G, Hess DC: Optimal delivery of minocycline to the brain: implication for human studies of acute neuroprotection. Expt Neurol 2004, 186:248\u2013251.","journal-title":"Expt Neurol"},{"key":"900_CR29","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0378-4347(91)80174-B","volume":"568","author":"RH B\u00f6cker","year":"1991","unstructured":"B\u00f6cker RH, Peter R, Machbert G, Bauer W: Identification and determination of the two principal metabolites of minocycline in humans. J Chromatogr 1991, 568:363\u2013374.","journal-title":"J Chromatogr"},{"key":"900_CR30","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/jac\/dkl224","volume":"58","author":"KN Agwuh","year":"2006","unstructured":"Agwuh KN, MacGowan A: Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines. J Antimicrob Chemother 2006, 58:256\u2013265.","journal-title":"J Antimicrob Chemother"},{"key":"900_CR31","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1128\/AAC.8.6.713","volume":"8","author":"M Barza","year":"1975","unstructured":"Barza M, Brown RB, Shanks C, Gamble C, Weinstein L: Relation between lipophilicity and pharmacological behaviour of minocycline, doxycycline, tetracycline, and oxytetracycline in dogs. Antimicrob Agents Chemother 1975, 8:713\u2013720.","journal-title":"Antimicrob Agents Chemother"},{"key":"900_CR32","first-page":"1061","volume":"176","author":"AL Aronson","year":"1980","unstructured":"Aronson AL: Pharmacotherapeutics of the newer tetracyclines. J Am Vet Med Assoc 1980, 176:1061\u20131068.","journal-title":"J Am Vet Med Assoc"},{"key":"900_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2003.11.012","volume":"149","author":"SG Kremlev","year":"2004","unstructured":"Kremlev SG, Roberts RL, Palmer C: Differential expression of cytokines and chemokine receptors during microglial activation and inhibition. J Neuroimmunol 2004, 149:1\u20139.","journal-title":"J Neuroimmunol"},{"key":"900_CR34","doi-asserted-by":"crossref","first-page":"7527","DOI":"10.4049\/jimmunol.166.12.7527","volume":"166","author":"TM Tikka","year":"2001","unstructured":"Tikka TM, Koistinaho JE: Minocycline provides neuroprotection against N -methyl-D-aspartate neurotoxicity by inhibiting microglia. J Immunol 2001, 166:7527\u20137533.","journal-title":"J Immunol"},{"key":"900_CR35","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.neuint.2005.04.018","volume":"47","author":"AL Wang","year":"2005","unstructured":"Wang AL, Yu ACH, Lau LT, Lee C, Wu LM, Zhu XA, Tso MOM: Minocycline inhibits LPS-induced retinal microglia activation. Neurochem Internat 2005, 47:152\u2013158.","journal-title":"Neurochem Internat"},{"key":"900_CR36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00401-009-0622-0","volume":"119","author":"MB Graeber","year":"2010","unstructured":"Graeber MB, Streit WJ: Microglia: biology and pathology. Acta Neuropathol 2010, 119:89\u2013105.","journal-title":"Acta Neuropathol"},{"key":"900_CR37","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11481-009-9163-5","volume":"4","author":"WJ Streit","year":"2009","unstructured":"Streit WJ, Xue QS: Life and death of microglia. J Neuroimmune Pharmacol 2009, 4:371\u2013379.","journal-title":"J Neuroimmune Pharmacol"},{"key":"900_CR38","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1471-4159.2005.03566.x","volume":"96","author":"K Sriram","year":"2006","unstructured":"Sriram K, Miller DB, O\u2019Callaghan JP: Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-\u03b1. J Neurochem 2006, 96:706\u2013718.","journal-title":"J Neurochem"},{"key":"900_CR39","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.nbd.2004.01.010","volume":"16","author":"M Tom\u00e1s-Camardiel","year":"2004","unstructured":"Tom\u00e1s-Camardiel M, Rite I, Herrera AJ, de Pablos RM, Cano J, Machado A, Venero JL: Minocycline reduces the lipopolysaccharide-induced inflammatory reaction, peroxynitrite-mediated nitration of proteins, disruption of the blood\u2013brain barrier, and damage in the nigral dopaminergic system. Neurobiol Dis 2004, 16:190\u2013201.","journal-title":"Neurobiol Dis"},{"key":"900_CR40","doi-asserted-by":"crossref","first-page":"13496","DOI":"10.1073\/pnas.96.23.13496","volume":"96","author":"J Yrj\u00e4nheikki","year":"1999","unstructured":"Yrj\u00e4nheikki J, Tikka T, Kein\u00e4nen R, Goldsteins G, Chan PH, Koistinaho J: A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci (USA) 1999, 96:13496\u201313500.","journal-title":"Proc Natl Acad Sci (USA)"},{"key":"900_CR41","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.nbd.2006.11.012","volume":"26","author":"C Zhao","year":"2007","unstructured":"Zhao C, Ling Z, Newman MB, Bhatia A, Carvey PM: TNF-\u03b1 knockout and minocycline treatment attenuates blood\u2013brain barrier leakage in MPTP-treated mice. Neurobiol Dis 2007, 26:36\u201346.","journal-title":"Neurobiol Dis"},{"key":"900_CR42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1742-2094-5-15","volume":"5","author":"CJ Henry","year":"2008","unstructured":"Henry CJ, Huang Y, Wynne A, Hanke M, Himler J, Bailey MT, Sheridan JF, Godbout JP: Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behaviour and anhedonia. J Neuroinflammation 2008, 5:15.","journal-title":"J Neuroinflammation"},{"key":"900_CR43","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","volume":"22","author":"DC Wu","year":"2002","unstructured":"Wu DC, Jackson-Lewis V, Vila M, Tieu K, Teismann P, Vadseth C, Choi DK, Ischiropoulos H, Przedborski S: Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci 2002, 22:1763\u20131771.","journal-title":"J Neurosci"},{"key":"900_CR44","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.nbd.2008.11.013","volume":"33","author":"HA Boger","year":"2009","unstructured":"Boger HA, Middaugh LD, Granholm AC, McGinty JF: Minocycline restores striatal tyrosine hydroxylase in GDNF heterozygous mice but not in methamphetamine-treated mice. Neurobiol Dis 2009, 33:459\u2013466.","journal-title":"Neurobiol Dis"},{"key":"900_CR45","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neurobiolaging.2006.03.013","volume":"28","author":"PL McGeer","year":"2006","unstructured":"McGeer PL, McGeer EG: NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies. Neurobiol Aging 2006, 28:639\u2013647.","journal-title":"Neurobiol Aging"},{"key":"900_CR46","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.biocel.2004.07.009","volume":"37","author":"EE Tuppo","year":"2005","unstructured":"Tuppo EE, Arias HR: The role of inflammation in Alzheimer\u2019s disease. Internat J Biochem Cell Biol 2005, 37:289\u2013305.","journal-title":"Internat J Biochem Cell Biol"},{"key":"900_CR47","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.2353\/ajpath.2007.070231","volume":"171","author":"T Kielian","year":"2007","unstructured":"Kielian T, Esen N, Lui S, Phulwani NK, Syed MM, Phillips N, Nishina K, Cheung AL, Schwartzman JD, Ruhe JJ: Minocycline modulates neuroinflammation independently of its antimicrobial activity in Staphylococcus aureus -induced brain abscess. Am J Pathol 2007, 171:1199\u20131214.","journal-title":"Am J Pathol"},{"key":"900_CR48","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.nbd.2010.11.008","volume":"41","author":"GW Kay","year":"2011","unstructured":"Kay GW, Jay NP, Palmer DN: The specific loss of GnRH-positive neurons from the hypothalamus of sheep with CLN6 neuronal ceroid lipofuscinosis occurs without glial activation and has only minor effects on reproduction. Neurobiol Dis 2011, 41:614\u2013623.","journal-title":"Neurobiol Dis"},{"key":"900_CR49","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1042\/BST0381448","volume":"38","author":"JD Cooper","year":"2010","unstructured":"Cooper JD: The neuronal ceroid lipofuscinoses: the same, but different? Biochem Soc Trans 2010, 38:1448\u20131452.","journal-title":"Biochem Soc Trans"},{"key":"900_CR50","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1292\/jvms.10-0072","volume":"72","author":"K Nibe","year":"2010","unstructured":"Nibe K, Nakayama H, Uchida K: Comparative study of cerebellar degeneration in canine neuroaxonal dystrophy, cerebellar cortical abiotrophy, and neuronal ceroid-lipofuscinosis. J Vet Med Sci 2010, 72:1495\u20131499.","journal-title":"J Vet Med Sci"},{"key":"900_CR51","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/hmg\/ddr019","volume":"20","author":"T Farfel-Becker","year":"2011","unstructured":"Farfel-Becker T, Vitner EB, Pressey SNR, Eilam R, Cooper JD, Futerman AH: Spatial and temporal correlation between neuron loss and neuroinflammation in a mouse model of neuronopathic Gaucher disease. Hum Mol Genet 2011, 20:1375\u20131386.","journal-title":"Hum Mol Genet"},{"key":"900_CR52","doi-asserted-by":"crossref","first-page":"15208","DOI":"10.1074\/jbc.M611907200","volume":"282","author":"M Nikodemova","year":"2007","unstructured":"Nikodemova M, Watters JJ, Jackson SJ, Yang SK, Duncan ID: Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC) \u03b1\/\u03b2II . J Biol Chem 2007, 282:15208\u201315216.","journal-title":"J Biol Chem"},{"key":"900_CR53","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jmb.2010.02.049","volume":"398","author":"D Dalm","year":"2010","unstructured":"Dalm D, Palm GJ, Aleksandrov A, Simonson T, Hinrichs W: Nonantibiotic properties of tetracyclines: structural basis for inhibition of secretory phopholipase A 2 . J Mol Biol 2010, 398:83\u201396.","journal-title":"J Mol Biol"},{"key":"900_CR54","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1074\/jbc.M110.169565","volume":"286","author":"S Schildknecht","year":"2011","unstructured":"Schildknecht S, Pape R, M\u00fcller N, Robotta M, Marquardt A, B\u00fcrkle A, Drescher M, Leist M: Neuroprotection by minocycline caused by direct and specific scavenging of peroxynitrite. J Biol Chem 2011, 286:4991\u20135002.","journal-title":"J Biol Chem"},{"issue":"136","key":"900_CR55","first-page":"1","volume":"1","author":"CJ Garwood","year":"2010","unstructured":"Garwood CJ, Cooper JD, Hanger DP, Noble W: Anti-inflammatory impact of minocycline in a mouse model of tauopathy. Front Psychiatry 2010,1(136):1\u20138.","journal-title":"Front Psychiatry"},{"key":"900_CR56","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/mds.23236","volume":"25","author":"H Schwarz","year":"2010","unstructured":"Schwarz H, Hickey C, Zimmerman C, Mazzoni P, Moskowitz C, Rosas D, McCall M, Sanchez-Ramos J, Perlmutter J, Wernle A, Higgins D, Nickerson C, Evans S, Kumar R, Miracle D, Dure L, Pendley D, Anderson K, Cines M, Ashizawa T, Stanton P, Fernandez H, Suelter M, Leavitt B, Decolongon J, Cudkowicz M, McDermott MP, Kieburtz K, Marshall F, Cha JH, Huntington Study Group DOMINO Investigators, et al.: A futility study of minocycline in Huntington\u2019s disease. Mov Disord 2010, 25:2219\u20132224.","journal-title":"Mov Disord"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-2094-10-97.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1742-2094-10-97\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-2094-10-97.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T15:40:09Z","timestamp":1646235609000},"score":1,"resource":{"primary":{"URL":"http:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/1742-2094-10-97"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,30]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["900"],"URL":"https:\/\/doi.org\/10.1186\/1742-2094-10-97","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,30]]},"article-number":"900"}}